Literature DB >> 23756102

The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models.

Stella E Panos1, A C Del Re, April D Thames, Timothy J Arentsen, Sapna M Patel, Steven A Castellon, Elyse J Singer, Charles H Hinkin.   

Abstract

Effective antiretroviral therapy has led to substantial improvements in health-related outcomes among individuals with HIV. Despite advances in HIV pharmacotherapy, suboptimal medication adherence remains a significant barrier to successful treatment. Although several factors have been associated with medication adherence in the extant literature, study assessing the effects of some of the neurobehavioral features specific to HIV has been limited. Moreover, although there is a growing body of literature measuring medication adherence in HIV prospectively, few employ advanced statistical methodologies suited to handle advanced models with multiple predictors that would strengthen our understanding of medication adherence trajectories in HIV. This study sought to integrate traditionally assessed predictors of medication adherence with neurobehavioral features of HIV in a longitudinal study of medication adherence to combined antiretroviral therapy (cART). The current study used multilevel modeling to examine a wide arrangement of categories of factors - demographic, medication related, psychosocial, and neurobehavioral - on medication adherence. The sample consisted of 235 HIV+ individuals whose medication adherence was monitored over the course of six months using electronic monitoring devices. After controlling for the effects of demographic, medication, and psychosocial factors, neurobehavioral features added predictive validity to the model. In the final model, simultaneously controlling for the effects of each of the predictors within all the categories, age, self-efficacy, executive functioning, apathy, and frequency of stimulant use emerged as unique individual predictors of average medication adherence across the 6-month study. Self-efficacy and irritability predicted changes in medication adherence over time. Adherence behavior is multidetermined. Adequate assessment of these factors, combined with timely intervention, appears to be warranted in order to boost adherence rates.

Entities:  

Mesh:

Year:  2013        PMID: 23756102      PMCID: PMC4408322          DOI: 10.1080/09540121.2013.802275

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  34 in total

1.  Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model.

Authors:  Mallory O Johnson; Margaret A Chesney; Rise B Goldstein; Robert H Remien; Sheryl Catz; Cheryl Gore-Felton; Edwin Charlebois; Stephen F Morin
Journal:  AIDS Patient Care STDS       Date:  2006-04       Impact factor: 5.078

2.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

3.  Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.

Authors:  Mark L Ettenhofer; Jessica Foley; Steven A Castellon; Charles H Hinkin
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

4.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

5.  Health literacy: an overlooked factor in understanding HIV health disparities.

Authors:  Chandra Y Osborn; Michael K Paasche-Orlow; Terry C Davis; Michael S Wolf
Journal:  Am J Prev Med       Date:  2007-11       Impact factor: 5.043

6.  Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.

Authors:  Allison J Applebaum; Mark A Richardson; Stephen M Brady; Deborah J Brief; Terence M Keane
Journal:  AIDS Behav       Date:  2008-08-09

7.  Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults.

Authors:  April D Thames; Jennifer Moizel; Stella E Panos; Sapna M Patel; Desiree A Byrd; Hector F Myers; Gail E Wyatt; Charles H Hinkin
Journal:  AIDS Patient Care STDS       Date:  2012-08-13       Impact factor: 5.078

8.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

9.  Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: a questionnaire survey.

Authors:  Eunseok Cha; Judith A Erlen; Kevin H Kim; Susan M Sereika; Donna Caruthers
Journal:  Int J Nurs Stud       Date:  2007-10-22       Impact factor: 5.837

10.  Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008.

Authors:  Linda Beer; James Heffelfinger; Emma Frazier; Christine Mattson; Brad Roter; Elizabeth Barash; Susan Buskin; Todd Rime; Eduardo Valverde
Journal:  Open AIDS J       Date:  2012-09-07
View more
  16 in total

1.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

2.  Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.

Authors:  Nicholas S Thaler; Philip Sayegh; Michelle S Kim; Steven A Castellon; Charles H Hinkin
Journal:  Arch Clin Neuropsychol       Date:  2015-01-14       Impact factor: 2.813

3.  High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults.

Authors:  Uraina S Clark; Lawrence H Sweet; Susan Morgello; Noah S Philip; Ronald A Cohen
Journal:  Brain Imaging Behav       Date:  2017-06       Impact factor: 3.978

4.  Cannabis Use, Medication Management and Adherence Among Persons Living with HIV.

Authors:  Denise C Vidot; Brenda Lerner; Raul Gonzalez
Journal:  AIDS Behav       Date:  2017-07

5.  Mental Health and Functional Competence in the Cape Town Adolescent Antiretroviral Cohort.

Authors:  Jacqueline Hoare; Nicole Phillips; Kirsty Brittain; Landon Myer; Heather J Zar; Dan J Stein
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

Review 6.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

7.  Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).

Authors:  Jori E Fleisher; Nabila A Dahodwala; Sharon X Xie; Mark Mayo; Daniel Weintraub; Joshua Chodosh; Judy A Shea
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

8.  Cognitive Training: Associations and Implications for Weight Management and Translational Research.

Authors:  Amanda N Szabo-Reed; Joseph E Donnelly
Journal:  Transl J Am Coll Sports Med       Date:  2021

9.  Association of self-reported executive function and mood with executive function task performance across adult populations.

Authors:  Sarahjane L Dube; Stacey Sigmon; Robert R Althoff; Kim Dittus; Diann E Gaalema; Doris E Ogden; Julie Phillips; Philip Ades; Alexandra S Potter
Journal:  Appl Neuropsychol Adult       Date:  2020-08-03       Impact factor: 2.050

10.  Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease.

Authors:  Michelle A Babicz; Steven Paul Woods; Pariya Fazeli; Erin E Morgan
Journal:  J Clin Psychol Med Settings       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.